The purpose of this review is, firstly, to outline briefly the various contractile mechanisms present in skeletal, cardiac, and smooth muscle and in other cells which contain similar mechanisms, and, secondly, to discuss the extent to which disturbances in these mechanisms can give rise to disease. The emphasis will be on those mechanisms that are particularly relevant to muscle disease, and conditions such as, for example, myasthenia gravis and experimental polymyositis that exemplify the pathological application of this newer cytophysiological information will be discussed. Reference will also be made to the pathological implications of the fact that actin and myosin and other rather similar proteins are not confined to skeletal, cardiac, and smooth muscle. Contractile elements of this kind, in conjunction with other structural proteins such as microtubules, are now thought to play a key role in the maintenance of cell shape in general, in the movement of intracellular constituents, and, indeed, in processes such as pinocytosis, phagocytosis, and secretion. It is not the presence of actin and myosin which distinguishes 'muscle cells' from 'non-muscle cells'. It is rather, firstly, the large proportion of the muscle cell cytoplasm occupied in muscle cells by the contractile proteins; secondly, the extent to which these proteins are organised into stable, highly oriented structures so arranged as to cause a specific change in the shape of the cell; and thirdly, the fact that 'muscle cells' themselves are organised into tissues that contract in a controlled and coordinated manner. This aside, what is fascinating for the pathologist is the possibility that diseases affecting specific contractile mechanisms-for example, the membrane changes which seem to characterise certain types of myotonia-may well be found to involve many other tissues not currently thought ofas part ofa contractile system.
Cell types
Skeletal muscle in man constitutes about one-third of the body-weight. It is composed of tubular multinucleate cells some 104-106 times greater in volume than a human leucocyte. Individual fibres average 40-80 ,um in diameter and may be as much as 300 mm in length (Lockhart and Brandt, 1938) . As in the case of the mononuclear cells of smooth muscle and cardiac muscle the bulk of the cytoplasm is occupied by 'contractile proteins'. SKELETAL MUSCLE Skeletal muscle (Fig. 1) varies considerably between species and, again, within a given species. This is obvious enough when one compares in man the high innervation ratio of the eye muscles (Peachey, 1966) or of the muscle fibres of the spindles (Swash and Fox, 1976) with that found in the extrafusal fibres that constitute the bulk of limb muscles. Moreover, in man, in a given muscle, different fibre-types are found inter-digitating with each other. Thus some muscle fibres (cells) contain abundant mitochondria and are rich in mitochondrial enzymes. Thesepredominate in postural or 'slow-twitch' muscles. They contrast with other fibres that are richer in glycogen and phosphorylase and predominate in 'fast-twitch' muscles. A critical factor in deciding the biochemical properties of the muscle fibre is the frequency of nerve-impulse reaching the fibre (Salmons and Sreter, 1976) . CARDIAC MUSCLE Cardiac muscle, although striated, is composed of mononuclear cells closely interdigitating with each other at the intercalated discs. At these discs various forms of apposition are noted between plasma membranes of adjacent cells. These junctions include the desmosomes, the fascia adhaerens, the tight junction, and (possibly) the gap junction (Fig. 2) . Desmosomal junctions provide a mechanical linkage between cells, while tight or gap junctions permit the passage of ions between adjacent cells and thus facilitate the spread of a wave of membrane depolarisation that constitutes the action potential. The pathology of these junctions has been little studied. . The same is probably true of the actins of platelets and leucocytes (Crawford, 1978) . Conversely, 'smooth muscle antibodies' can react with the actins and myosins of 'non-muscle' cells (Farrow et al., 1971) heads' in electronmicrographs (Huxley, 1963) . This 'decoration' of actin filaments with the head groups Biochemical anatomy of myosin is used as a means of identifying these actin filaments by electron microscopy in extracts from Although actins, myosins, and associated 'contractile' 'non-muscle cells' (see Ishikawa et al., 1969) . Another proteins are present in most cells (Table) they are characteristic of 'cytoplasmic' but not skeletal highly organised in skeletal and cardiac muscle, muscle actin is that some microfilaments are rather less so in smooth muscle, and even less so in disrupted by the drug cytochalasin B, a fungal other cells. This organisation results in the character-product (Sanger et al., 1971) . Immunofluorescence istic striations of striated muscle (Fig. 5 ) and cardiac reveals that actin forms a complicated network muscle and in the oriented contraction of these and throughout the cell (Lazarides, 1976a) and that at smooth muscle,.
least some of the actin filaments are attached to the Skeletal muscle contracts by the sliding of thick plasma membrane, probably by a protein resembling myosin filaments relative to thin actin filaments ot-actinin (Schollmeyer et al., 1974b ),a protein found (Fig. 6a, b) (Huxley, 1957; Huxley, 1963) , and at the Z line of striated muscle (Schollmeyer et Shortland) 1974a). There is evidence that myosin too may be embedded in the plasma membranes of some cells (Willingham, et al., 1974) .
Components of the 'contractile' system of musclefor example, myosin (Weber and Groeschel-Stewart, 1974) and tropomyosin (Lazarides, 1976b) -are also detectable in, for example, fibroblasts by fluorescent antibody tracing techniques. These proteins are not readily identifiable by electron microscopy, so their relationship with the actin molecules is not known although hypothetical models have been proposed (for example, Loor, 1976) . Actin-like filaments and cx-actinin are also thought to be responsible for the 'pumping' action of microvilli, projections a few microns in length that form the brush-border of the epithelium of the small intestine (Mooseker and Tilney, 1975) (Rees et al., 1977) . This framework can readily be demonstrated, for example, throughout the cytoplasm of the fibroblast (Weber, 1975) . Microtubules are disrupted by colchicine and vinblastin. Exactly how they participate in the movement of intracellular constituents is still obscure.
They are involved, for example, in phagocytosis, in the secretory processes of liver and pancreatic cells, and in platelet contraction (see Borgers and De Brabander, 1975) . They play, too, a key role in mitosis in that they largely constitute the mitotic spindle and probably participate also in axoplasmic transport (see Ochs, 1971; Sloper and Grainger, 1975) , perhaps in conjunction with 'contractile proteins' (Bray, 1977) . However, the best understood role of microtubules in cell movement relates to the 'beating' of cilia. Here dynein arms appear to cause a sliding movement between neighbouring pairs ('doublets') of microtubules (Fig. 9 ). Dynein is a protein which, like myosin, possesses ATPase activity (Gibbons and Rowe, 1965) . Muscle cells, apart from the highly oriented arrangement of their 'contractile proteins', differ from most tissue cells in that their contractile activities are co-ordinated. Thus in skeletal muscle (Fig. 6a ) an impulse which arrives at the motor nerve terminal results in the release of acetylcholine. This diffuses across the narrow space between nerve terminal and the muscle cell surface to become bound to an acetylcholine receptor protein located in the motor end-plate region of the muscle fibre. Binding initiates a local depolarisation which is then propagated over the entire plasma membrane of the muscle fibre and down the tubular invaginations of the plasma membrane (the T system) deep into the muscle fibre.
Depolarisation of the T system causes Ca++ release from sac-like portions of the sarcoplasnic reticulum (endoplasmic reticulum of muscle), which lie closely applied to the tubules of the T system. These Ca++ ions become bound to troponin (Fig. 6b showing the sarcomere components, the sacs of sarcoplasmic (endoplasmic) reticulum, the way in which these sacs are apposed to the T-tubule system (thus forming the Triad), the continuation of the wall of the T-tubule system with the plasma membrane, and the relationship of the acetylcholine receptor sites to the motor nerve terminaL. (b) Diagrammatic representation of the components of the 'thin' filaments. Also shown is the interaction between the head groups of myosin in the 'thick' filaments with actin of the 'thin' filament. Cakcium released from the sarcoplasmic reticulum binds to a subunit of the Troponin complex thus causing a conformational change in that complex. This change allows tropomyosin to move, thus unmasking the myosin-binding sites of monomers (G-actin) of the F-actin filament. (c) Diagram showing relative movement of the 'thin' and 'thick' filaments during muscle contraction. In step 1 a myosin head group, with bound ADP and P1 (inorganic phosphate), becomes attached to a G-actin monomer at site 1 on the 'thin' filament. The myosin head group undergoes a conformational change such that the angle between the head group and the tail of the myosin molecule in the 'thick' filament is altered. This results in the 'thin' filament being moved (to the left in the diagram) along the 'thick' filament (step 2). As the result of hydrolysis of ATP by the ATPase activity of the myosin head group, the myosin molecule becomes detachedfrom the G-actin monomer at site 1 (step 3): the angle between the head group and the tail of the myosin molecule reverts to its 'resting' configuration opposite a different part of the actin filament (step 4). In a singk sarcomere, if one imagines contraction drawing together the Z-lines of the sarcomere, the actin filaments will move in relation to stationary myosin filaments. Small and Squire, 1972) .
A-band. The sarcomere is thus shortened. The myosin head-groups then release their hold on actin, a process requiring the hydrolysis of ATP by the ATPase activity of the myosin head-group. Sustained contraction is achieved by the repetition of this cycle (Fig. 6c) . Contraction ceases as Ca++ ions are pumped back into the sarcoplasmic sacs. This causes a fall in the concentration of calcium ions in the region of the myofibrils and thus the release of these ions from the myofibrils-that is, from troponin. The cessation of contraction follows the return of the tropomyosin molecule to the position where it prevents interaction of myosin head groups with actin (see Huxley (1972) for a more detailed description).
It is of pathological interest that in rigor mortis, because of the lack of ATP, the head-groups of myosin cannot detach themselves from actin fibrils to which they are bound. In osteomalacia muscle weakness may reflect an abnormality in the sequestration of calcium ions by the sarcoplasmic reticulum (Schott and Wills, 1976) . This process in vitamin-D deficient rabbits seems to result from the impaired ability of sarcoplasmic reticulum to concentrate calcium ions (Curry et al., 1974) .
The mode of action of the actins and myosins found in 'non-muscle' cells such as fibroblasts is obscure. The use of cytochalasin-B as a disrupter of cytoplasmic actin filaments (microfilaments) led to the suggestion that actin and myosin participate in a wide variety of cellular processes (Wessells et al., 1971) . In non-muscle cells actin and myosin may by their interaction contribute to locomotion, modification of cell shape, endocytosis and exocytosis, and division of the cell body. Hypothetical examples of such mechanisms are shown in Fig. 10 . Equally, generation of tension by fibroblasts during wound contraction and by platelets during clot retraction probably reflect in part the interaction of actin and myosin.
Development, hyperplasia, growth, and repair
The cellular mechanisms underlying the initial development, growth, and repair of skeletal muscle seem to be essentially the same. It was long thought that injured skeletal muscle was repaired almost entirely by scar tissue, but it has been widely recognised in recent years that muscle repair is accompanied by abundant new muscle formation (Sloper and Pegrum, 1967) . The underlying mechanisms of muscle regeneration were once commonly thought to be by amitotic division of muscle nuclei (Godman, 1958.) This theory is now largely discarded (Fischman, 1972) . Current thought is largely based on the studies of Holtzer (see Lash et al., 1957, and Konigsberg, 1963) . Their work suggested that myonuclei-that is, the nuclei of muscle fibres and of their precursors the multinucleate myotubesdo not divide. Mitotic division is confined to mononuclear muscle-cell precursors, which fuse together to form myotubes (Fig. 11) .
Convincing evidence in favour of the fusion of mononuclear precursors during development has been provided by Mintz and Baker (1967) . They combined the morulae of different strains of mice, thus producing mosaics. By using isoenzymes as markers they showed that hybrid isoenzymes were produced in the skeletal muscle of such mice-that is, that these animals contain fibres that must have arisen by fusion of cells derived from two different strains of mouse.
Gross changes in musculature are induced in a variety of conditions-for example, in skeletal muscle after training and in the uterine wall in pregnancy. These changes are commonly attributed to the hypertrophy of muscle cells rather than to the formation of new cells. The explanation is probably an over-simplification. Thus the rapid induction of hypertension in the rat is accompanied by a proliferation of arteriolar smooth muscle but not of cardiac muscle cells as judged by the uptake of tritiated thymidine (Crane and Ingle, 1965 ; see Shortland et al., Walker (1963) in particular established the relevance of these findings to muscle repair in vivo. Mononuclear muscle cell precursors are probably derived from satellite cells or from myonuclei segregated from the cytoplasm of injured muscle fibres, although other possibilities such as the derivation of myoblasts from interstitial cells or from exogenous, perhaps circulating, cells (Fig. 12 ) have yet to be excluded (Sloper and Pegrum, 1967; Bayliss and Sloper, 1973) .
Whether fibroblasts or myoblasts can migrate through tissues is still undecided. Abercrombie (1978) reports (see page 1) that fibroblast scan move in vitro. We have been studying grafts of minced skeletal muscle (Studitsky, 1974) (Partridge and Sloper, 1977) . Now it has been shown that when normal skin is transplanted into the skin of a patient with Hunter's syndrome (a mucopolysaccharidosis associated with mental deficiency) there is an increased urinary secretion of glycosaminoglycans (see M. F. Dean (Dean, 1978) at page 120). This suggests that the transplanted fibroblasts have made up in part for the deficient cx-L-idurono-2-sulphate sulphatase in the grafted patient (Dean et al., 1976) . It would be very exciting if in the nearfuturewecould similarlyattempt to insert normal myoblasts into patients with congenital muscle disorders. Because muscle cells are multinucleate and because the gene products of individual nuclei seem to be shared, at least to some extent, within the fibre (Mintz and Baker, 1967) new normal myonuclei could possibly make up for an enzyme deficiency in an abnormal muscle fibre.
It should be added that the differentiation of myotubes into muscle fibres is accompanied by the migration of myonuclei to the periphery of the cell. Moreover, once newly formed muscle fibres become innervated by motor nerve terminals acetylcholine receptors become restricted to small areas on the surface (Diamond and Miledi, 1962) (Hoffman, 1951) . Reinnervation in this way imposes upon the muscle fibre the enzyme type ('fast' or 'slow') characteristic of the nerve (Romanul and Van der Meulen, 1966; Bullen et al., 1969; McComas, 1977) . End-plates (and motor terminals) vary greatly in their shape in disease; they are particularly large in myasthenia gravis.
Diseases of contractile mechanisms in 'non-muscle' cells POSSIBLE ACTIN ABNORMALITY IN POLYMORPHONUCLEAR LEUCOCYTES
An abnormally functioning actin has recently been reported (Boxer et al., 1974) in the polymorphonuclear neutrophil leucocytes (PMN) of an infant suffering from recurrent bacterial infections and unable to produce pus. The phagocytic activity of this patient's monocytes was normal, but the locomotion and particle-ingestion of his PMN were much impaired (Fig.13) . Myosin andtubulinextracted from PMN appeared normal by electrophoresis, whereas actin monomers, although present, failed to polymerise normally. The most conspicuous morphological abnormality was the formation of few and thin pseudopodia in PMN spread on glass and the development of few filament-rich pseudopodia, as seen by electron microscopy. It has similarly been suggested (Booyse et al., 1972) that an abnormality of platelet actomyosin ('thrombasthenin') may explain the failure of platelet aggregation and clot retraction seen in Glanzmann's thrombasthenia, a bleeding disorder.
POSSIBLE MICROTUBULAR ABNORMALITY IN POLYMORPHONUCLEAR LEUCOCYTES
A defect in microtubular function may underlie a further genetically-determined syndrome, the Chediak-Higashi syndrome, characterised by abnormal PMN function and by the presence of giant lysosomes in such cells (Oliver, 1975) . In man the features include albinism and nystagmus and frequent pyogenic infections (Blume and Wolff, 1972 (Fig. 10) . PMN function is impaired when G-actin cannot polymerise, endocytosis is diminished, and locomotion impaired. (After Boxer et al., 1974) colchicine, which disrupts microtubules, causes normal PMN to behave like those in the ChediakHigashi mouse. Whether the fault lies in the microtubular proteins themselves or in the mechanisms controlling microtubular assembly and disassembly has not been fully investigated. We owe to the pioneer work of Malawista (1975) our knowledge of the way in which microtubules contribute to PMN function and the degranulation of lysosomes.
ABNORMAL DYNEIN-MICROTUBULAR SYSTEM IN DISEASES AFFECTING CILIA
A generalised disease involving the dynein-microtubular system, the 'immotile-cilia' syndrome, has recently been characterised in man (Afzelius, 1976; Eliasson et al., 1977) . The assembly of dynein on to the tubulin of microtubules of flagella and cilia is affected (see Fig. 9 for normal structure). There may be an underlying deficiency in the synthesis or assembly of dynein or in the proper attachment of dynein to microtubules. Male patients are infertile and, as in Kartagener's syndrome, have chronic respiratory disease. These are attributed to flagellar and ciliary dysfunction, respectively, in spermatozoa and bronchi. There may also be malposition of the viscera, a reduced sense of smell, headaches, and J. C. Sloper, M. C. Barrett, and T. A. Partridge mental depression. Electronmicrographs of cilia of the respiratory tract and of sperm flagella show a lack of the dynein 'arms' seen in the normal cilium (Fig. 9a) .
Diseases of smooth muscle
Diseases of smooth muscle are usually attributed to disturbances in control mechanisms. This applies to the megacolon of Hirschsprung's disease, in which it is widely accepted that the prime abnormality is in the autonomic innervation of the large intestine.
A well-recognised change, however, which primarily affects the muscle cells themselves is the accumulation of lipofuscin pigment in atrophic smooth muscle. This can be so excessive as to justify the term 'brown bowel' disease, a form of lipofuscinosis in which large amounts of this pigment can be seen in the smooth muscle of the gut and also in that of the arterioles (see Fig. 3 ). This is sometimes associated with malabsorption or with low vitamin-E concentration in the plasma (Fox, 1967 (Gutmann and Zak, 1961 used to demonstrate receptor sites (Fischbach and Cohen, 1973) . Interest at present centres on what is probably the commonest variety of the myasthenic syndromenamely, that in which a circulating antibody blocks the acetylcholine receptor sites. In such myasthenic subjects the number of sites that will bind labelled bungarotoxin is diminished (Fambrough et al., 1973) . Circulating antibody is present in many patients . Removal of this antibody by plasmapheresis greatly alleviates the myasthenia J. C. Sloper, M. C. Barrett, and T. A. Partridge (Pinching et al., 1976b) . Evidence of localisation of IgG and C3 at the motor end-plate of myasthenic patients has been presented by Engel and his coworkers (Engel et al., 1977b) . This strongly confirms the idea (Simpson, 1960 ) that myasthenia gravis may have an autoimmune basis.
The key experimental model is based on the injection of acetylcholine receptor material with complete Freund's adjuvant into rats. The receptors are derived from the electric organs of the eel (Electrophorus electricus). There is an initial phase (Engel et al., 1976) , 24 hours or so after the onset of weakness, characterised by mononuclear, neutrophil, and rare eosinophil infiltration of the end-plate region. Engel's ultrastructural studies are quite extraordinarily thorough and reveal macrophages at this stage entering the gaps between the separating clefts of the end-plate. This phase may be accompanied by evidence of a disturbance in cell-mediated immunity , although the disorder can be induced by the transfer ofantibody from affected animals (Lindstrom et al., 1976a) . The chronic phase is essentially humoral and characterised by the appearance of circulating antibody against receptor sites and degeneration of the endplate receptor site.
Other varieties of myasthenia gravis, which do not appear to involve autoimmunity, are encountered occasionally (Pinching et al., 1976; Engel et al., 1977a (McComas, 1977) . Myotonia congenita and myotonia dystrophica are both characterised by this phenomenon. In the latter there is an associated muscle degeneration.
The myotonia in these conditions may reflect a disturbance in the biophysical and biochemical properties of the muscle plasma membrane. The key observations are derived from studies made in human patients (Lipicky and Bryant, 1973) and in goats with a similar syndrome (Bryant and MoralesAguilera, 1971 ) which have revealed a decreased chloride-permeability of the muscle membrane.
In skeletal muscle a wave of depolarisation of the resting potential is propagated along the plasma membrane and down the T (transverse) tubule system. The normal muscle plasma membrane is The muscle cell freely permeable to potassium ions, which diffuse out of the fibre to restore the resting potential after depolarisation. Adrian and Bryant (1974) hold that in normal muscle the high Cl-permeability of the membranes of the T-system helps to compensate for the reduced resting potential caused by build-up of potassium ions in the tubules during repetitive muscle stimulation. In myotonic goats the membrane permeability to Cl-is decreased so that repetitive stimulation diminishes the resting potential in the membranes of the T tubules: this renders these membranes likely to 'fire' spontaneously.
The underlying biochemical abnormality in the muscle membrane is uncertain. Analyses of muscle and ofred cell membranes from affected subjectshave shown differences between normal and myotonic subjects with respect to membrane fluidity (Butterfield et al., 1974) , fatty acid content (Kuhn, 1973) , and the phosphorylating ability of protein kinases (Roses and Appel, 1973) .
This use of red cells for membrane studies in muscle disease is exciting great interest. The underlying inference is that a crucial membrane disturbance in muscle may be reflected in other tissues. Interestingly enough, an abnormally high proportion of red cells in patients with Duchenne muscular dystrophy can be shown to have hedgehog-like projections ('echinocytes') . This change certainly suggests a cell-membrane abnormality (Matheson and Howland, 1974) .
Myopathies associated with abnormal myosins Although inherited disorders of myosin have yet to be defined in man such a disorder has been seen in a 'floppy' mutant of a nematode worm (Caenorhabditis elegans). Microscopically there is a marked deficiency in myofibrils. This is attributed to a deficiency in one of the genes coding for one of the heavy chains of myosin (MacLeod et al., 1977) . The quest for abnormal myosins and other enzymes in human myopathies of unknown cause is an active field of contemporary research.
A genetic disorder of myofibril formation has also been reported in the axolotl. This probably reflects an abnormality of cardiac myosin (Lemanski, 1974) . Cardiac muscle is involved in diseases such as Duchenne dystrophy regarded as primarily skeletal myopathies (Walton and Natrass, 1954) .
Myopathies with other specific biochemical disturbances These are well reviewed by Dubowitz and Brooke (1973) and Gardner-Medwin (1977) . Some, such as the malignant hyperthermia associated with muscle destruction which develops in susceptible patients under anaesthesia, are little understood. Many of these patients have a high plasma CK level. Nelson (1973) has suggested that the underyling disorder is a failure of the sarcoplasmic reticulum to concentrate Ca++.
Rather better analysed are the glycogenoses (Ryman, 1974) in which the enzymes of glycogen metabolism are lacking. These disorders can affect many tissues, but in McArdle's disease (McArdle, 1951 ) the deficient phosphorylase seems to be specific to muscle. We have recently seen a variant of McArdle's disease in which the condition was associated with the curious morphological change which characterises another myopathy-namely, 'central core disease' (Fig. 14) .
Lipid myopathies are described, for example, where there is a deficiency in carnitine palmityl transferase (DiMauro and DiMauro, 1973) or carnitine (Engel and Angelini, 1973 (Dubowitz and Brooke, 1973) . These diseases are thought to be confined to skeletal and sometimes cardiac muscle. What is not known about many of these conditions is the extent to which they may or may not involve 'non-muscle' cells.
Polymyositis
Idiopathic polymyositis is a progressive, sometimes fatal inflammation of muscle of no known cause. First well characterised by Walton and Adams (1958) , a good experimental model was developed by Dawkins (1965) who injected whole rabbit muscle homogenate with complete Freund's adjuvant into guinea-pigs. Our findings corroborate and extend those initiated by Kakulas (1966) and Currie (1971) . Our aim was to clarify the way in which muscle was attacked. We used Dawkins's model, which yielded an active myositis with myonecroses in almost all animals appropriately injected and killed at the height of the disease (Fig. 15) . We also developed a method of quantifying lesions. The high reproducibility of the disease allowed us to determine which ultracentrifugal fraction of muscle on injection yielded most lesions.
Only the myofibrillar fraction yielded lesions comparable with those obtained with whole muscle homogenate (Manghani et al., 1974) . Curiously, this fraction had not been tested byothers, although some -for example, Morgan et al. (1971) -obtained a myositis with a mitochondrial fraction. Our work does not rule out the possibility that the critical antigenic substance in muscle may lie in a membranous or other component brought down in the myofibrillar fraction. It strongly suggests, however, that the myofibrillar fraction is the most effective in producing a myositis.
We next studied the role of serum and of lymphocytes in the production of the disease. Sensitised lymphocytes transferred from animals with active myositis caused the disease in 16 out of 20 recipient animals, but transferred serum did not in any of 10 animals studied. The role of antibody has yet to be excluded. We found high levels of circulating antibody in animals with myositis. Just possibly we did not give sufficient antibody in our transfer experiment to produce a myositis.
The question we then asked ourselves was: Against what fraction of muscle are lymphocytes from such animals sensitised? We found that they were sensitised against whole muscle homogenate and myofibrillar subfractions such as myosin and tropomyosin but not against troponin .
The next question was: How do sensitised lymphocytes find and gain access to the interior of the muscle cell? In human polymyositis one can suppose that there is some change in the muscle cell surface which excites the immune system in such away that it attacks the subject's own muscle cells. Injection of muscle and Freund's complete adjuvant possibly mimics this process, modifying the immune system of the body in such a way that lymphocytes will attack muscle. Indeed, Kakulas (1966) showed that lymphocytes from myositic animals would destroy tissuecultured muscle cells. We studied the way in which such lymphocytes adhered preferentially to muscle cells in tissue culture before destroying these cells, and we developed a method of quantifying preferential adherence . Such adherence was maximal when muscle lesions were most frequent. Treatment with antilymphocytic serum blocked both the disease and the preferential attachment of the lymphocytes to muscle. It blocked too the development of lymphocytes sensitised against specific muscle fractions (Fig. 16) .
The two tests we used are proving effective guides in the diagnosis of human polymyositis. In these studies the macrophage migration inhibition test has been replaced by the leucocyte migration inhibition test.
We have no idea what precipitates the immune disturbance in polymyositis but it is commonly speculated, as mentioned above, that there may be a virus-induced alteration in a muscle surface antigen that causes muscle cells to be attacked by the subject's own lymphocytes. Our findings suggest that this attack is characterised by a reaction between sensitised lymphocytes and antigens on the muscle cell surface, by the rupture of the muscle cell membrane, and the subsequent reaction of sensitised lymphocytes with specific 'contractile protein' within the muscle cell. It remains to be seen whether any comparable diseases affect other 'contractile' cells of the body.
